The business may not be as strong as its performance this year suggests.
The "Protein Engineering for Pharmaceutical Biotechnology Training Course (Jan 21st - Jan 22nd, 2026)" training has been added to ResearchAndMarkets.com's offering. Enhance your knowledge in protein ...
China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...
Jan 30 () - CSPC Pharmaceutical Group said on Friday it had entered an agreement with UK drugmaker AstraZeneca for the ...
Vertex Pharmaceuticals' late-stage pipeline. Vertex Pharmaceuticals' strategy is to develop medicines in areas with high ...
Amsterdam, the Netherlands, January 7, 2026 – Scenic Biotech, a pioneer in the field of modifier therapies for severe diseases, today announced a license and research agreement with Ono Pharmaceutical ...
DOVER, DE, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- The safety of parenteral medicines and medical devices ...
In our final batch of Changing Faces columns for 2025, we’re detailing a flurry of senior leadership appointments in recent months, with companies across the spectrum in experienced executives to ...
Hosted on MSN
Why Ultragenyx Pharmaceutical (RARE) Is the Biotech Stock with the Biggest Upside Potential
We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Ultragenyx Pharmaceutical, Inc. (NASDAQ:RARE) stands ...
North Carolina, ranked in the top five states for life sciences by Business Facilities, is home to a thriving ecosystem specializing in bio and pharmaceutical manufacturing. Propelled by a low cost of ...
During the first six months of this year, the pharmaceutical-biotech industry completed construction on a total of 31 new plants and research centers across North America During the first six months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results